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Purpose: To identify the genetic defect in two Pakistani families with autosomal recessive achromatopsia.
Methods: Two families (RP26 and RP44) were originally diagnosed with retinal dystrophy based upon their medical
history. To localize the causative genes in these families, homozygosity mapping was performed using Affymetrix 10K
single nucleotide polymorphism (SNP) arrays. Sequence analysis was used to find the mutations in candidate genes cyclic
nucleotide-gated channel alpha-3 (CNGA3; family RP26) and cyclic nucleotide-gated channel beta-3 (CNGB3; family
RP44). Control individuals were analyzed by allele-specific PCR for the CNGA3 mutation and BstXI restriction analysis
for the CNGB3 mutation. After genetic analysis, clinical diagnosis was re-evaluated by electroretinography and color
vision testing. During the course of this study, selected affected members of family RP26 were given pink glasses as
supportive therapy.
Results: Sequence analysis of the positional candidate genes identified a novel missense mutation in CNGA3 (c.822G>T;
p.R274S) in family RP26, and a novel CNGB3 frameshift mutation (c.1825delG; p.V609WfsX9) in family RP44. Clinical
re-evaluation after genetic analysis revealed that both families have segregating autosomal recessive achromatopsia.
Conclusions: Genetic analysis of two Pakistani families with retinal disease enabled the establishment of the correct
diagnosis of achromatopsia. Two novel mutations were identified in CNGA3 and CNGB3 that are both specifically
expressed in cone photoreceptors. Re-evaluation of the clinical status revealed that both families had achromatopsia. The
use of pink glasses in patients was helpful in reducing photophobia and enabled rod-mediated vision.
Achromatopsia (ACHM; OMIM 216900) is a congenital
autosomal recessive cone disorder with a prevalence of 1 in
30,000  individuals  [1].  The  clinical  features  include  low
visual acuity, nystagmus, photophobia, severe color vision
defects, and no recordable or only residual cone function on
electroretinography  (ERG)  with  normal  rod  functions.
Fundoscopy is usually normal, although macular pigmentary
changes and atrophy have been described in the literature
[2-5]. ACHM is characterized by progressive cone loss, which
has been described in a large proportion of patients in terms
of the worsening of the macular appearance and deterioration
of the central vision irrespective of the genetic cause [5,6]. It
has been reported that the use of red contact lenses or red tinted
glasses can alleviate photophobia in patients with ACHM or
cone dystrophy [7,8].
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To date, ACHM has been described as being caused by
mutations  in  four  genes:  cyclic  nucleotide-gated  channel
alpha-3  (CNGA3),  cyclic  nucleotide-gated  channel  beta-3
(CNGB3),  guanine  nucleotide-binding  protein,  alpha-
transducing  activity  polypeptide  2  (GNAT2),  and
phosphodiesterase 6C (PDE6C) [9-14]. The proteins encoded
by  these  four  genes  are  specifically  expressed  in  cone
photoreceptor  cells,  where  they  have  been  shown  to  be
involved  in  the  cone  phototransduction  cascade.  CNGA3
encodes the α-subunit and CNGB3 the β-subunit of the cyclic
nucleotide-gated (CNG) channel that has a central function in
signal transduction of the visual pathway [15]. 25% of all
ACHM patients carry mutations in CNGA3, and 45%–50%
carry CNGB3 mutations, whereas only a few families have
been reported to have GNAT2 or PDE6C mutations [14-18].
Mutations in CNGA3,CNGB3, and PDE6C have also been
associated  with  cone  dystrophy  in  a  small  proportion  of
patients [10,14].
In the present study, we report two Pakistani families
(RP26 and RP44) which were initially classified as having
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774retinal dystrophy, but after performing genetic analysis they
were reclassified as having ACHM.
METHODS
Initial  diagnosis:  Two  families  (RP26  and  RP44)  were
collected from different areas of Pakistan. Family RP26 was
collected from the Punjab province, while RP44 was collected
from the North West Frontier Province. After documenting
the  initial  clinical  histories,  both  families  were  initially
diagnosed to suffer from retinal dystrophy.
Ethics  declaration:  This  study  conforms  to  the  Helsinki
declaration  and  was  approved  by  the  Shifa  College  of
Medicine/Shifa  International  Hospital  Ethics  Committee/
Institutional Review Board (Islamabad, Pakistan). All patients
were informed in their local language of the purpose of the
study, and gave their informed written consent before they
were further analyzed.
Genetic analysis:
DNA isolation and marker analysis—For family RP26,
blood  samples  were  collected  from  16  individuals  (four
affected and 12 healthy individuals) from a six generation
pedigree (Figure 1A). For family RP44, blood samples were
collected from eight individuals (two affected and six normal
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Figure 1. Pedigrees and genotyping results of Pakistani achromatopsia (ACHM) families RP26 and RP44. A: Pedigree with marker haplotypes
for cyclic nucleotide-gated channel alpha-3 (CNGA3) at 2q11.2 for family RP26. White circles represent healthy females, filled circles affected
females, white squares healthy males, and filled squares affected males. Deceased individuals are shown with a slanting line across the symbol.
Haplotypes were constructed for a 9.1-Mb interval on chromosome 2q11.2, encompassing the CNGA3 gene (indicated with an arrowhead).
B: Family RP44 and segregation of the c.1825delG mutation (M) in CNGB3 (+ represents the wild type alleles).individuals)  from  a  four-generation  pedigree  (Figure  1B).
DNA isolation was performed as described previously [19].
All the affected members of family RP26 (IV-1, V-2, V-3,
VI-2),  and  seven  individuals  of  family  RP44  (healthy
individuals  III-2,  IV-2,  IV-4,  IV-6,  IV-7  and  affected
individuals  IV-1  and  IV-3)  were  genotyped  using  the
Affymetrix 10K single nucleotide polymorphism (SNP) array
containing 10,204 SNPs (Affymetrix, Santa Clara, CA).
Multipoint parametric linkage analysis of the SNP array
data of both families was performed using the GeneHunter
program in the EasyLinkage software package (version 5.02)
[20]. Fine-mapping of the region on chromosome 2q11.2 with
the highest logarithm (base 10) of odds (LOD) score in family
RP26 was conducted using microsatellite markers that were
amplified  by  the  polymerase  chain  reaction  (PCR)  under
standard conditions. Haplotypes were constructed based upon
the size of the alleles of the microsatellites. The positions of
the microsatellite markers were derived from the Marshfield
map. Two-point parametric LOD scores for the microsatellite
markers  were  calculated  using  the  SuperLink  program
(version 1.6) in the EasyLinkage software package [20].
Sequencing of candidate genes: The sequencing primers for
the candidate genes CNGA3 and CNGB3 have been described
before [5]. For family RP26, the seven coding exons of the
CNGA3 gene were sequenced in one affected individual (V-2)
along with a control sample, and for family RP44, all 18
coding  exons  of  the  CNGB3  gene  were  sequenced  in
individual IV-1 as well as a control sample. The amplified
PCR products were separated on agarose gel and purified with
a  Nucleospin  DNA  extraction  kit  (Nucleospin  Extract  II,
Macherey-Nagel GmbH and Co, Germany). Purified products
were directly sequenced using the corresponding primers and
dye-termination chemistry (BigDye Terminator, version 3 on
a 3730 or 2100 DNA analyzer; Applied Biosystems, Foster
City, CA).
Segregation analysis and panel screening: Segregation of the
CNGA3 mutation in family RP26, and analysis of the mutation
in 22 unrelated probands with autosomal recessive retinal
dystrophies and 150 ethnically-matched control individuals,
was performed via allele-specific PCR [21]. For this purpose,
three primers were designed; a forward wild type (5′-AAA
GGT GGG CAC AAA CTA CCC AGA AGT GAG G-3′),
forward mutant (5′-AAA GGT GGG CAC AAA CTA CCC
AGA AGT GAG T-3′) and a common reverse primer (5′-AAT
GGC AAA GTA GAT GCA GGC ATT CCA GTG G-3′).
DNA was amplified using 0.5 mM dNTPs, 1.5 mM MgCl2,
0.3 μM of each forward and reverse primer, and 2.5 U Taq
polymerase. The thermal cycling conditions were as follows:
initial denaturation at 95 °C for 5 min, followed by 35 cycles
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Figure 2. Sequence analysis and amino
acid conservation of the mutated cyclic
nucleotide-gated  channel  alpha-3
(CNGA3) amino acid residue in family
RP26. A: Sequence trace of part of exon
8 in a normal control individual (left
panel) and an affected individual (V-2;
right panel) showing the homozygous
mutant sequence c.822G>T (p.R274S).
B:  Protein  sequence  alignment  of
CNGA3  in  different  species.  The
mutated  arginine  residue  is  highly
conserved. The conserved amino acids
between different species are shown in
black  boxes,  and  the  less  conserved
amino acids are highlighted in light gray
or white boxes.at 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s, with a
final extension cycle at 72 °C for 6 min.
Segregation analysis for the CNGB3 mutation in family
RP44  was  performed  by  direct  sequencing  of  exon  16.
Screening of 44 probands with retinal dystrophies for this
CNGB3 mutation was performed by amplification of exon 16
(357  bp)  followed  by  BstXI  digestion  of  the  amplified
products. Wild-type alleles were digested into 183 bp and 174
bp fragments, whereas mutant alleles remained undigested.
Clinical re-evaluation: Due to the specific genetic defect that
was identified, the affected members of family RP26 were
clinically revisited and a detailed clinical examination was
performed to confirm the status of the disease in the family.
Fundoscopy and electroretinogram (ERG) data were obtained
for both families. Visual acuity tests were performed for the
affected individuals (IV-1, V-2, and VI-2) of family RP26,
and they were also subjected to color differentiation tests
using the standard Ishihara plates. Family RP44 could not be
revisited  for  the  visual  acuity  test,  but  a  detailed  clinical
history  was  documented  from  the  proband  (IV-1)  of  the
family. The affected members of family RP26 were also given
pink glasses to use for the alleviation of photophobia.
RESULTS
Initial  clinical  results:  Initially,  both  families  (RP26  and
RP44)  were  diagnosed  as  having  retinal  dystrophy.  This
diagnosis was based on their clinical history, because the
patients complained about vision loss and nystagmus.
Homozygosity mapping: In family RP26, whole-genome SNP
array analysis revealed a homozygous interval of 9.1 Mb at
2q11.2  between  SNP  rs718159  and  rs1375002  in  all  the
affected members, with a multi-point LOD score of 3.81 at
theta  0.  Confirmation  and  refinement  of  this  region  was
performed  by  analyzing  microsatellite  markers  between
flanking  SNPs  rs718159  and  rs1375002.  As  a  result,  the
critical region for the underlying defect was refined from the
initial 9.1 Mb to 7.2 Mb, flanked by markers rs718159 and
D2S2229 (Figure 1A). This region contains the CNGA3 gene,
which has previously been implicated in ACHM and cone
dystrophy [9]. In family RP44, homozygosity was observed
at  nine  different  chromosomal  regions  in  both  affected
members (IV-1, IV-3), with a LOD score of 1.22 at theta 0,
whereas the unaffected individuals III-2, IV-2, IV-4, IV-6,
and IV-7 were heterozygous in these regions. The CNGB3
gene, which has also previously been shown to be involved in
ACHM and cone dystrophy, resides in one of these regions on
chromosome 8q21.3 [11].
Sequence analysis: Sequence analysis of all the coding exons
of the CNGA3 gene in the proband of family RP26 revealed a
novel change of nucleotide G>T at position 822 (c.822G>T)
in exon 8 in the affected family member V-2. This nucleotide
change results in the substitution of a serine residue for an
arginine  residue  (p.R274S;  Figure  2A).  The  mutation
segregates with the disease in the family, and the mutation was
not  detected  in  22  unrelated  probands  with  autosomal
recessive retinal dystrophies, or in 150 ethnically-matched
controls.
Sequencing of all the coding exons of the CNGB3 gene
in the proband of family RP44 resulted in the identification of
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Figure  3.  Sequence  analysis  of  cyclic  nucleotide-gated  channel
beta-3 (CNGB3) in family RP44. Sequence trace of part of exon 16
in a normal control individual (upper panel), an affected individual
carrying a homozygous c.1825delG mutation (middle panel), and a
heterozygous carrier of the mutation (lower panel).a novel mutation, a one nucleotide deletion at position 1825
in exon 16 of the gene c.1825delG; Figure 3A), which results
in  a  frameshift  and  premature  termination  of  the  protein
(p.V609WfsX9). Segregation analysis in the family revealed
that  the  two  affected  individuals,  IV-1  and  IV-3,  are
homozygous for the mutation, while four healthy persons
(III-2, IV-2, IV-4, IV-7) are heterozygous carriers, and two
healthy persons (IV-5, IV-6) are homozygous for the wild type
allele (Figure 1B and Figure 3A). The c.1825delG mutation
was not identified in 44 probands with retinal dystrophies.
Clinical re-evaluation: As it has previously been reported that
mutations in CNGA3 and CNGB3 are associated with cone
dysfunction  [9-11],  the  clinical  status  of  the  affected
individuals from both families was re-evaluated. The affected
individuals of family RP26 (IV-1 and VI-2), who were aged
35 and 11 years, respectively, at the time of fundoscopy,
showed  a  normal  macular  region.  However,  one  affected
individual from each family (RP26_V-2 [age 14 years] and
RP44_IV-1 [age 19 years]) showed the beginning of a Bull’s
eye maculopathy (Figure 4), and revealed some residual cone
responses  on  the  photopic  ERG  on  the  30  Hz  flicker
stimulation (Figure 5), showing that the disease is progressive
in these patients.
The  affected  individuals  from  family  RP26  had
congenital nystagmus, photophobia and were color blind. In
addition, the affected individuals (IV-1, V-2, and VI-2) had
low visual acuity of 20/200, 20/400, and 20/200, respectively.
Members of family RP44 could not be revisited for the visual
acuity test because they live in a very remote rural area. In this
family,  a  detailed  telephone  interview  with  both  affected
members IV-1 and IV-3 revealed that they also had congenital
nystagmus. In addition, they had photophobia along with low
visual  acuity  and  were  found  to  be  color  blind,  thereby
confirming the molecular diagnosis of ACHM.
In  previous  studies,  affected  individuals  with  cone-
dysfunction have been treated with red colored-tinted glasses
or  red  contact  lenses  to  reduce  photophobia  [7,8].  To
determine whether this would also help in family RP26, the
affected individuals (IV-1, V-2) were given pink glasses to
wear. After continuous use of the glasses for two months, a
significant decrease in photophobia was observed in these
patients.
DISCUSSION
In  this  study,  we  identified  two  Pakistani  families  with
autosomal recessive ACHM. All affected individuals had an
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Figure  4.  Fundus  photographs  of
affected individuals from families RP26
and  RP44.  Fundus  photographs  of
affected individual V-2 of family RP26
A, B) and IV-1 of family RP44 (C, D).
Patient  RP26_V-2  and  patient
RP44_IV-1 show the beginning signs of
a  Bull’s  eye  maculopathy  (indicated
with an arrowhead).Molecular Vision 2010; 16:774-781 <http://www.molvis.org/molvis/v16/a87> © 2010 Molecular Vision
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Figure 5. Electroretinogram (ERG) of
the normal and affected members of the
families RP26 and RP44. The photopic
ERGs  (A,  C)  of  the  unaffected
individuals (RP26_IV:2, RP44_IV:6) of
families  RP26  and  RP44  indicated
normal cone responses. In comparison,
the  affected  individuals  (RP26_V:2,
RP44_IV:1)  of  both  families  had
residual cone responses (B, D).early onset of nystagmus, photophobia and low visual acuity
with color blindness. In these two families, novel mutations
were identified in CNGA3 (c.822G>T, p.R274S) and CNGB3
(c.1825delG, p.V609WfsX9).
There are six cyclic nucleotide gated (CNG) channels
present in mammals, and these are divided in two subfamilies,
the A subunits (CNGA1–4) and the B subunits (CNGB1 and
CNGB3). The CNGA3 and CNGB3 channels play a critical
role in cone-mediated vision, which is required for central and
color vision, as well as visual acuity. CNGA3 and CNGB3
encode the cone CNG channel subunits [22] that are able to
form heterotetramers [23], although CNGA3 subunits may
also form homotetramers [24]. Mutations in these two genes
have been shown to result in different forms of ACHM and
cone dystrophy [23].
In  CNGA3,  the  p.R274S  mutation  is  located  in  a
conserved region (Figure 2B), which is part of the fourth
transmembrane helix (S4) [17]. The arginine residue at this
position is conserved among the CNG alpha subunits of rods
(CNGA1)  and  olfactory  neurons  (CNGA2),  Shaker  K+
channels and HCN channels [25]. Mutations in the S4 domain
have  been  shown  to  cause  failure  in  cellular  channel
processing. Mutant channel proteins are not glycosylated, and
do  not  reach  the  surface  plasma  membrane;  they  remain
trapped in the endoplasmic reticulum, and are most likely
misfolded [25].
The c.1825delG mutation in exon 16 of CNGB3 should
in theory give rise to nonsense-mediated decay of the mutant
RNA, and can, therefore, be considered a loss-of-function
mutation.  In  case  there  is  residual  CNGB3  mRNA,  the
predicted  truncated  protein  (p.V609WfsX9)  lacks  the
conserved  cyclic  nucleotide-monophosphate  (cNMP)
domain. The cNMP domain is the binding site for cyclic
nucleotides, and is involved in the cyclic nucleotide mediated
activation of the protein. It is hypothesized that both putative
effects  of  this  variant  will  lead  to  the  loss-of-function  of
CNGB3.
Identification of causative mutations aided in the correct
diagnosis of ACHM in these two Pakistani families, which
had  previously  been  diagnosed  to  suffer  from  retinal
dystrophy. After the correct re-diagnosis of the disease, the
use of pink glasses reduced the photophobia to some extent in
the affected individuals of family RP26. Due to the use of
these  dark  colored  pink  glasses,  the  light  exposure  was
reduced, resulting in increased scotopic vision that helped the
patients to see objects at a distance, even during the day time.
In this study, we report the first genetic screening and use of
dark glasses as supportive therapy for ACHM in Pakistan, a
disease that is often misdiagnosed.
ACKNOWLEDGMENTS
This work was supported by grant no. 530 awarded (to R.Q.)
by the Higher Education Commission of Pakistan. A part of
the funding for this work was provided by a core grant of the
Shifa College of Medicine, Islamabad, Pakistan. This work
was also financially supported by the Foundation Fighting
Blindness,  USA  (to  A.I.d.H.).  We  would  also  like  to
acknowledge the Higher Education Commission of Pakistan
for awarding an IRSIP Scholarship to M.A. to perform part of
the research at the Radboud University Nijmegen Medical
Centre, Nijmegen, the Netherlands. The studies of A.A.H.J.T.
and S.R. were financially supported by the Prof. Dr. Henkes
Stichting,  Nijmeegse  Oogonderzoek  Stichting,  Stichting
Wetenschappelijk Onderzoek Oogziekenhuis (SWOO), The
Rotterdam Eye Hospital, Macula Degeneratie Fonds (MD
Fonds), Algemene Nederlandse Vereniging ter Voorkoming
van Blindheid (ANVVB), Dr. F.P. Fischer Stichting, Gelderse
Blinden  Stichting,  Landelijke  Stichting  voor  Blinden  en
Slechtzienden  (LSBS),  Stichting  Blindenhulp,  Stichting
Blinden-penning,  Stichting  Nederlands  Oogheelkundig
Onderzoek  (SNOO),  Stichting  Ondersteuning
Oogheelkunde’s-Gravenhage (OOG), and the Stichting ter
Verbetering van het Lot der Blinden Nederland.
REFERENCES
1. Rojas CV, Maria LS, Santos JL, Corte F, Alliende MA. A
frameshift insertion in the cone cyclic nucleotide gated cation
channel causes complete achromatopsia in a consanguineous
family  from  a  rural  isolate.  Eur  J  Hum  Genet  2002;
10:638-42. [PMID: 12357335]
2. Sharpe LT, Nordby K. Total colour blindness: an introduction.
In: Hess RF, Sharpe LT, Nordby K, editors. Night vision:
basic,  clinical  and  applied  aspects.  Cambridge  (NY):
Cambridge University Press; 1990. p. 253–289.
3. Varsanyi  B,  Wissinger  B,  Kohl  S,  Koeppen  K,  Farkas  A.
Clinical and genetic features of Hungarian achromatopsia
patients. Mol Vis 2005; 11:996-1001. [PMID: 16319819]
4. Ruther K, Sharpe LT, Zrenner E. Dual rod pathways in complete
achromatopsia. Ger J Ophthalmol 1994; 3:433-9. [PMID:
7866265]
5. Thiadens AA, Slingerland NW, Roosing S, van Schooneveld
MJ, van Lith-Verhoeven JJ, van Moll-Ramirez N, van den
Born  LI,  Hoyng  CB,  Cremers  FP,  Klaver  CC.  Genetic
etiology  and  clinical  consequences  of  complete  and
incomplete  achromatopsia.  Ophthalmology  2009;
116:1984-9. [PMID: 19592100]
6. Kohl S, Varsanyi B, Antunes GA, Baumann B, Hoyng CB, Jagle
H, Rosenberg T, Kellner U, Lorenz B, Salati R, Jurklies B,
Farkas A, Andreasson S, Weleber RG, Jacobson SG, Rudolph
G, Castellan C, Dollfus H, Legius E, Anastasi M, Bitoun P,
Lev  D,  Sieving  PA,  Munier  FL,  Zrenner  E,  Sharpe  LT,
Cremers FPM, Wissinger B. CNGB3 mutations account for
50% of all cases with autosomal recessive achromatopsia. Eur
J Hum Genet 2005; 13:302-8. [PMID: 15657609]
7. Park WL, Sunness JS. Red contact lenses for alleviation of
photophobia  in  patients  with  cone  disorders.  Am  J
Ophthalmol 2004; 137:774-5. [PMID: 15059731]
8. Young RS, Krefman RA, Fishman GA. Visual improvements
with red-tinted glasses in a patient with cone dystrophy. Arch
Ophthalmol 1982; 100:268-71. [PMID: 6978127]
9. Kohl S, Marx T, Giddings I, Jagle H, Jacobson SG, Apfelstedt-
Sylla  E,  Zrenner  E,  Sharpe  LT,  Wissinger  B.  Total
Molecular Vision 2010; 16:774-781 <http://www.molvis.org/molvis/v16/a87> © 2010 Molecular Vision
780colourblindness is caused by mutations in the gene encoding
the  alpha-subunit  of  the  cone  photoreceptor  cGMP-gated
cation channel. Nat Genet 1998; 19:257-9. [PMID: 9662398]
10. Thiadens AA, Roosing S, Collin RW, van Moll-Ramirez N, van
Lith-Verhoeven JJ, van Schooneveld MJ, den Hollander AI,
van  den  Born  LI,  Hoyng  CB,  Cremers  FP,  Klaver  CC.
Comprehensive analysis of the achromatopsia genes CNGA3
and CNGB3 in progressive cone dystrophy. Ophthalmology
2010; 117:825-30. [PMID: 20079539]
11. Kohl  S,  Baumann  B,  Broghammer  M,  Jagle  H,  Sieving  P,
Kellner U, Spegal R, Anastasi M, Zrenner E, Sharpe LT,
Wissinger B. Mutations in the CNGB3 gene encoding the
beta-subunit of the cone photoreceptor cGMP-gated channel
are  responsible  for  achromatopsia  (ACHM3)  linked  to
chromosome  8q21.  Hum  Mol  Genet  2000;  9:2107-16.
[PMID: 10958649]
12. Sundin OH, Yang JM, Li Y, Zhu D, Hurd JN, Mitchell TN, Silva
ED, Maumenee IH. Genetic basis of total colourblindness
among  the  Pingelapese  islanders.  Nat  Genet  2000;
25:289-93. [PMID: 10888875]
13. Aligianis IA, Forshew T, Johnson S, Michaelides M, Johnson
CA,  Trembath  RC,  Hunt  DM,  Moore  AT,  Maher  ER.
Mapping of a novel locus for achromatopsia (ACHM4) to 1p
and identification of a germline mutation in the alpha subunit
of  cone  transducin  (GNAT2).  J  Med  Genet  2002;
39:656-60. [PMID: 12205108]
14. Thiadens AAHJ, den Hollander AI, Roosing S, Nabuurs SB,
Zekveld-Vroon RC, Collin RW, Baere ED, Koenekoop RK,
van Schooneveld MJ, Strom TM, van Lith-Verhoeven JJC,
Lotery AJ, van Moll-Ramirez N, Leroy BP, van den Born LI,
Hoyng  CB,  Cremers  FPM,  Klaver  CCW.  Homozygosity
mapping reveals PDE6C mutations in patients with early-
onset cone photoreceptor disorders. Am J Hum Genet 2009;
85:240-7. [PMID: 19615668]
15. Reuter  P,  Koeppen  K,  Ladewig  T,  Kohl  S,  Baumann  B.
Achromatopsia  Clinical  Study  Group,  Wissinger  B.
Mutations in CNGA3 impairs trafficking or function of cone
cyclic nucleotide-gated channels, resulting in achromatopsia.
Hum Mutat 2008; 29:1228-36. [PMID: 18521937]
16. Rosenberg T, Baumann B, Kohl S, Zrenner E, Jorgensen AL,
Wissinger  B.  Variant  phenotypes  of  incomplete
achromatopsia in two cousins with GNAT2 gene mutations.
Invest  Ophthalmol  Vis  Sci  2004;  45:4256-62.  [PMID:
15557429]
17. Wissinger B, Gamer D, Jagle H, Giorda R, Marx T, Mayer S,
Tippmann  S,  Broghammer  M,  Jurklies  B,  Rosenberg  T,
Jacobson SG, Sener EC, Tatlipinar S, Hoyng CB, Castellan
C, Bitoun P, Andreasson S, Rudolph G, Kellner U, Lorenz B,
Wolff G, Verellen-Dumoulin C, Schwartz M, Cremers FPM,
Apfelstedt-Sylla E, Zrenner E, Salati R, Sharpe LT, Kohl S.
CNGA3  mutations  in  hereditary  cone  photoreceptor
disorders.  Am  J  Hum  Genet  2001;  69:722-37.  [PMID:
11536077]
18. Kohl S, Baumann B, Rosenberg T, Kellner U, Lorenz B, Vadala
M,  Jacobson  SG,  Wissinger  B.  Mutations  in  the  cone
photoreceptor  G-protein  alpha-subunit  gene  GNAT2  in
patients  with  achromatopsia.  Am  J  Hum  Genet  2002;
71:422-5. [PMID: 12077706]
19. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A
Laboratory Manual. 2nd ed. Cold Spring Harbor (NY): Cold
Spring Harbor Laboratory Press; 1989.
20. Lindner TH, Hoffmann K. easyLINKAGE: A PERL script for
easy  and  automated  two-/multi-point  linkage  analyses.
Bioinformatics 2005; 21:405-7. [PMID: 15347576]
21. Little  S.  Amplification-refractory  mutation  system  (ARMS)
analysis of point mutation. In: Boyle AL, editors. Current
protocols in human genetics. New York: John Wiley and
Sons; 2000. p. 9.8.1–9.8.12.
22. Kaupp UB, Seifert R. Cyclic nucleotide-gated ion channels.
Physiol Rev 2002; 82:769-824. [PMID: 12087135]
23. Matveev AV, Quiamao A, Fitzgerald B, Ding X. Native cone
photoreceptor  cyclic  nucleotide-gated  channel  is  a
heterotetrameric  complex  comprising  both  CNGA3  and
CNGB3: a study using the cone dominant retina of Nrl−/−
mice. J Neurochem 2008; 106:2042-55. [PMID: 18665891]
24. Wissinger B, Muller F, Weyand I, Schuffenhauer S, Thanos S,
Kaupp  UB.  Cloning,  chromosomal  localization  and
functional expression of the gene encoding the α-subunit of
the cGMP-gated channel in human cone photoreceptors. Eur
J Neurosci 1997; 9:2512-21. [PMID: 9517456]
25. Faillace MP, Bernabeu RO, Korenbrot JI. Cellular processing
of cone photoreceptor cyclic GMP-gated ion channels: a role
for  the  S4  structural  motif.  J  Biol  Chem  2004;
279:22643-53. [PMID: 15024024]
Molecular Vision 2010; 16:774-781 <http://www.molvis.org/molvis/v16/a87> © 2010 Molecular Vision
The print version of this article was created on 26 April 2010. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
781